GT Biopharma (OXIA.F) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-2.56
-1.81
-1.05
-0.29

Details

Expected EPS
-0.5836848
Actual EPS
-0.472098
Surprise EPS
0.11
Surprise Percent
+19.12%

Description

GT Biopharma (OXIA.F) has reported earnings of -0.472098 per share for Q3 2025.

0 Comments

Share your thoughts